Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrocorticographic Changes and Neuronal Maturation in the Antidepressant-like and Anxiolytic Effects of Micro- or Macrodosing of <i>Psilocybe cubensis</i> Mushroom in Mice.

Molecules (Basel, Switzerland)·2026
Same author

Antidepressant-like effect of hydroxytyrosol in a 1-methyl-4-phenylpyridinium model of Parkinson's disease in rats.

Neurochemical research·2026
Same author

NMDA receptor antagonism requires serotonin and noradrenaline to induce antidepressant-like effects in a treatment-resistant depression rat model.

European journal of pharmacology·2026
Same author

Role of Nitric Oxide in the Antidepressant Effect of an Aqueous Extract of <i>Punica granatum</i> L.: Effects on GSH/GSSG Ratio and Lipoperoxidation in Adult Male Swiss Webster Mice.

International journal of molecular sciences·2025
Same author

Independence of Peripheral Brain-Derived Neurotrophic Factor from Depression and Anxiety Symptoms in Cocaine Use Disorder: An Initial Description.

International journal of molecular sciences·2025
Same author

Subchronic Intranasal Administration of NeuroEPO Reduces Long-Term Consequences of Severe Traumatic Brain Injury in Male Rats.

Antioxidants (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Antidepressant effects of estrogens: a basic approximation.

Erika Estrada-Camarena1, Carolina López-Rubalcava, Nelly Vega-Rivera

  • 1Instituto Nacional de Psiquiatría Ramón de la Fuente, México.

Behavioural Pharmacology
|August 12, 2010
PubMed
Summary
This summary is machine-generated.

Estrogens show antidepressant-like effects and enhance the efficacy of common antidepressants like fluoxetine. Their action involves monoaminergic systems and estrogen receptors, with outcomes varying by estrogen type, dose, and patient factors.

More Related Videos

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

Ovariectomy and 17&beta;-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

Related Experiment Videos

Last Updated: Jun 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

Ovariectomy and 17&beta;-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

Area of Science:

  • Neuroendocrinology
  • Pharmacology
  • Molecular Psychiatry

Background:

  • Estrogenic compounds have shown controversial results as antidepressants or coadjuvants.
  • Factors influencing estrogen's antidepressant actions require further investigation from a basic research perspective.

Purpose of the Study:

  • To review the potential factors underlying the antidepressant actions of estrogens alone or in combination with other antidepressants.
  • To analyze the mechanisms of action focusing on monoaminergic systems and estrogen receptors.

Main Methods:

  • Review of basic research on estrogenic compounds and their interaction with antidepressants.
  • Analysis of studies involving selective serotonin reuptake inhibitors (fluoxetine), selective noradrenaline reuptake inhibitors (desipramine), and mixed serotonin/noradrenaline reuptake inhibitors (venlafaxine).
  • Investigation of the role of monoaminergic systems, estrogen receptors, and specific antagonists (WAY100635, idaxozan, RU 58668).

Main Results:

  • Estrogen's antidepressant effect is influenced by type, duration, dose, sex, time after ovariectomy, and age.
  • Estrogens potentiate the antidepressant-like action of fluoxetine, venlafaxine, and desipramine, significantly reducing their onset time.
  • Antagonists for serotonin 1A receptors, alpha2 adrenergic receptors, and estrogen receptors blocked the antidepressant-like effects.

Conclusions:

  • Estrogens exhibit antidepressant-like properties independently.
  • Estrogens significantly facilitate the therapeutic action of clinically used antidepressants.
  • The antidepressant effects of estrogens involve both monoaminergic pathways and classical estrogen receptors.